Showing results (1-10 of 294) with videos related to
Sort By:
Pageof 30
Journal of Hypertension|February 28, 2008
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trialRoland E Schmieder, Sverre E Kjeldsen, Stevo Julius, et al.Pharmacological Research|November 12, 2017
Hypertension and cardiovascular risk: General aspectsSverre E KjeldsenEuropean Journal of Internal Medicine|February 15, 2015
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3Ingar Holme, Sverre E KjeldsenCurrent Hypertension Reports|January 17, 2017
The Un-Observed Automated Office Blood Pressure Measurement Technique Used in the SPRINT Study Points to a Standard Target Office Systolic Blood Pressure <140 mmHgSverre E Kjeldsen, Giuseppe ManciaAmerican Heart Journal|November 4, 2004
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersSverre E Kjeldsen, Stevo JuliusCurrent Vascular Pharmacology|July 15, 2010
A link between hypertension and atrial fibrillation: methods of treatment and preventionTonje A Aksnes, Sverre E KjeldsenJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 12, 2005
Lowering blood pressure for cardiovascular risk reductionGordon T McInnesJournal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2003
The differences between ACE inhibitor-treated and calcium channel blocker-treated hypertensive patientsGordon T McInnesClinical Therapeutics|August 5, 2004
How important is optimal blood pressure control?Gordon T McInnesPageof 30